Cargando…
Pricing and reimbursement of orphan drugs: the need for more transparency
Pricing and reimbursement of orphan drugs are an issue of high priority for policy makers, legislators, health care professionals, industry leaders, academics and patients. This study aims to conduct a literature review to provide insight into the drivers of orphan drug pricing and reimbursement. Al...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3132155/ https://www.ncbi.nlm.nih.gov/pubmed/21682893 http://dx.doi.org/10.1186/1750-1172-6-42 |